FDA Approves Acalabrutinib to Treat CLL/SLL
November 21, 2019
As part of Project Orbis, The FDA has approved acalabrutinib for the treatment of adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.
Recent Content
Sex Disparity in Recurrence Score Among Patients with Early Stage ER-Positive Breast Cancer
November 21, 2019
Oncotype DX® Breast Recurrence Scores from the National Cancer Database indicated that a lower threshold is needed for male patients with early stage ER-positive breast cancer to predict mortality.
Phase III B-MIND Study Passes Futility Analysis for Patients with DLBCL
November 21, 2019
MorphoSys announced that their ongoing phase III B-MIND study of tafasitamab passed the interim analysis for futility in patients with relapsed or refractory diffuse large B-cell lymphoma.
FDA Accepts Biologics License Application for Bevacizumab Biosimilar
November 21, 2019
Samsung Bioepis announced that the FDA accepted a biologics license application for SB8, a biosimilar candidate for bevacizumab.
Phase III HERO Study Meets Primary Efficacy Endpoint in Men with Advanced Prostate Cancer
November 20, 2019
Myovant announced that their phase III HERO study of relugolix met its primary efficacy end point and all 6 secondary endpoints in men with advanced prostate cancer.
Martin H. Voss, MD, on Bringing Different Disciplines Together at IKCS
November 20, 2019
The medical oncologist discusses the different talks that were presented at the International Kidney Cancer Symposium in Miami.
David Braun, MD, PhD, on the Unique Experiences at IKCS
November 20, 2019
The next gen innovator discusses the integration of fields at the International Kidney Cancer Symposium in Miami.
Kathryn Arbour, MD, on the Development of KRAS G12C Inhibitors in Lung Cancer
November 19, 2019
The MSK expert discusses exciting advancements in the field of immunotherapy for treating lung cancer at the Annual New York Lung Cancers Symposium®.
Opioid Use in Prostate Cancer Clinical Trials Appears to Vary by World Region
November 19, 2019
An international study of prostate cancer clinical trials discovered that opioid use appears to differ by region, implying that a variability should be considered.
Expert Says Next Generation Sequencing Revolutionizing Molecular Diagnostics
November 19, 2019
Biomarker testing allows doctors to go beyond what’s under the microscope, helping to determine the best patient therapy.
